OCUL
OCULAR THERAPEUTIX, INC
NASDAQ · Healthcare · Biotechnology · US
$7.14
+4.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 21.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.02x
- Price / sales
- 30.12x
- Price / cash flow
- -6.58x
Enterprise value
- Enterprise value
- $1.0B
- EV / sales
- 20.15x
- EV / EBITDA
- -3.69x
- EV / EBIT
- -3.34x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026